BREAKING: NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria

0
225
A health worker prepares an injection of the AstraZeneca/Oxford Covid-19 vaccine on February 7, 2021 at the Mignot Hospital in Le Chesnay near Paris. The top French medical authority Haute autorité de Santé has approved the vaccine for use in France, but only for people under 65, echoing decisions made in Sweden, Germany, Belgium and Switzerland over concerns about a lack of data on the effectiveness of the vaccine for over 65s.
ALAIN JOCARD / AFP

The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.

The Director-General of NAFDAC, Dr. Mojisola Adeyeye made the announcement during a live briefing on Thursday.

NAFDAC DG, Dr. Mojisola Adeyeye briefs journalists on the use of AstraZeneca Vaccine in Nigeria

She said that the vaccine can be stored at 2 to 8-degree centigrade.

According to the DG, there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.

Dr Adeyeye disclosed that the South African variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.

The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).

READ  COVID-19 Cases In Europe Exceed 12 Million

LEAVE A REPLY

Please enter your comment!
Please enter your name here